FindTrial
Sign In

A registry study of clinical indicators during extracorporeal life support in patients with novel coronavirus infection

A registry study of clinical indicators during extracorporeal life support in patients with novel coronavirus infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067947
Enrollment
Unknown
Registered
2023-02-01
Start date
2023-01-28
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus-infection

Interventions

Case series:NA

Sponsors

Fuwai Hospital, CAMS&PUMC
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age of 18-85 years old; 2. receiving cardiac surgery under CPB or ECMO support; 3. SARS-CoV-2 nucleic acid positive nasopharyngeal or oropharyngeal swabs within 72 hours before receiving CPB or ECMO; 4. Informed consent was signed.

Exclusion criteria

Exclusion criteria: 1. participated in other intervention studies within 1 month and had a great impact on this study; 2. Allergic to CPB or ECMO circuits; 3. expected survival time less than 24 hours; 4. patients with other conditions deemed by the investigators to be unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
heparin resistance;—

Secondary

MeasureTime frame
Routine coagulation monitoring;heparin monitor;anticoagulation protein;anticoagulation factors;endothelial function;inflammatory factors;lymphocyte subpopulation;autoimmunity;NETS;The oxygenator exports the nucleic acid of SARS-CoV-2;—

Countries

China

Contacts

Public ContactBingyang Ji

Fuwai Hospital, CAMS&PUMC

jibingyang@fuwai.com+86 13801251767

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026